Home

Addus HomeCare Corporation - Common Stock (ADUS)

96.19
+2.20 (2.34%)

Addus Homecare Corp is a leading provider of home healthcare services in the United States, specializing in delivering personalized, compassionate care to individuals in the comfort of their own homes

The company offers a comprehensive range of services, including skilled nursing, physical therapy, and assistance with daily living activities, catering primarily to seniors and those with chronic illnesses or disabilities. By focusing on quality and patient-centered care, Addus aims to enhance the quality of life for its clients while also supporting their families. The company operates through a network of home health agencies, expanding its reach and improving access to essential healthcare services across various communities.

SummaryNewsPress ReleasesChartHistoricalFAQ
BrightSpring Health Services (BTSG) Q4 Earnings: What To Expect
Healthcare services provider BrightSpring Health Services (NASDAQBTSG) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Via StockStory · March 5, 2025
Analyst Expectations For Addus HomeCare's Futurebenzinga.com
Via Benzinga · February 27, 2025
What To Expect From Chemed’s (CHE) Q4 Earnings
Healthcare services company Chemed Corporation (NYSECHE) will be reporting results tomorrow after market hours. Here’s what to expect.
Via StockStory · February 25, 2025
Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect
Alternate site health provider Option Care Health (NASDAQOPCH) will be reporting earnings tomorrow before market open. Here’s what to look for.
Via StockStory · February 25, 2025
Addus HomeCare (NASDAQ:ADUS) Surprises With Q4 Sales
Home healthcare provider Addus HomeCare (NASDAQADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of $1.38 per share was 1.6% above analysts’ consensus estimates.
Via StockStory · February 24, 2025
Deep Dive Into Addus HomeCare Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 24, 2025
Is NASDAQ:ADUS a Suitable Choice for Quality Investing?chartmill.com
Why Quality Investors May Find ADDUS HOMECARE CORP (NASDAQADUS) Attractive.
Via Chartmill · January 16, 2025
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing?chartmill.com
Should Quality-Oriented Investors Explore ADDUS HOMECARE CORP (NASDAQADUS)?
Via Chartmill · December 19, 2024
Earnings Scheduled For February 24, 2025benzinga.com
Via Benzinga · February 24, 2025
Assessing Addus HomeCare: Insights From 9 Financial Analystsbenzinga.com
Via Benzinga · November 4, 2024
The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Expertsbenzinga.com
Via Benzinga · October 11, 2024
Demystifying Addus HomeCare: Insights From 8 Analyst Reviewsbenzinga.com
Via Benzinga · September 23, 2024
Cracking The Code: Understanding Analyst Reviews For Addus HomeCarebenzinga.com
Via Benzinga · September 3, 2024
Addus HomeCare (ADUS) To Report Earnings Tomorrow: Here Is What To Expect
Home healthcare provider Addus HomeCare (NASDAQADUS) will be reporting earnings tomorrow after market hours. Here’s what to look for.
Via StockStory · February 23, 2025
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSEBKD) and its peers.
Via StockStory · February 14, 2025
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSECHE) and its peers.
Via StockStory · February 14, 2025
Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQBTSG).
Via StockStory · February 11, 2025
Analyst Scoreboard: 6 Ratings For Addus HomeCarebenzinga.com
Via Benzinga · August 6, 2024
Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQADUS) and its peers.
Via StockStory · February 11, 2025
DaVita Stock Sees Improved Relative Strength Ratinginvestors.com
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
Via Investor's Business Daily · December 20, 2024
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analystbenzinga.com
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth.
Via Benzinga · December 16, 2024
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · December 16, 2024
AdaptHealth Stock Earns RS Rating Upgradeinvestors.com
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81.
Via Investor's Business Daily · September 17, 2024
Reasonable growth and debt and a high ROIC for ADDUS HOMECARE CORP (NASDAQ:ADUS).chartmill.com
ADDUS HOMECARE CORP (NASDAQADUS) may be suited for quality investing, we'll explore why in this article.
Via Chartmill · September 3, 2024
ADUS Stock Earnings: Addus HomeCare Beats EPS, Beats Revenue for Q2 2024investorplace.com
ADUS stock results show that Addus HomeCare beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024